November, 2024
November 2024
M T W T F S S
 123
45678910
11121314151617
18192021222324
252627282930  
5 papers about lung cancer suggested by Stephen Liu
Aug 5, 2024, 14:36

5 papers about lung cancer suggested by Stephen Liu

Stephen Liu, Head of Developmental Therapeutics at Georgetown Lombardi Comprehensive Cancer Center, shared a few must-reads papers on X:

1. Foritinib in advanced ROS1-rearranged non-small-cell lung cancer in China: a multicentre, open-label, single-arm, phase 2 study

Authors: Jin-Ji Yang, Jianying Zhou, Si-Yang Maggie Liu, Mingjun Li, Zhiye Zhang, Ying Cheng, Yun Fan, Hongming Pan, Baoqing Wang, Gongyan Chen, Ke Wang, Liyan Jiang, Yanping Hu, Jianhua Shi, Xiaorong Dong, Cuimin Ding, Yunpeng Liu, Zhe Liu, Wangjun Liao, Wei Li, Jun Wang, Shanyong Yi, Qiong Zhao, Aimin Zang, Yuan Chen, Jiuwei Cui, Pengfei Luo, Xionghu Shen, Meili Sun, Changli Wang, Yi-Long Wu

Stephen Liu

2. Immune-related adverse events requiring hospitalization in patients with lung cancer: implications and insights

Authors: Ayo Falade, Leyre Zubiri, Chia-Yun Wu, Katherine Perlman, Joie Sun, Nora Hathaway, Kelley Grealish, Jackie Lopiccolo, Kerry Reynolds, Meghan Mooradian

Stephen Liu

3. Treatment patterns and outcomes in KRASG12C‐positive advanced NSCLC patients previously treated with immune checkpoint inhibitors: A Canada-wide real-world, multi-center retrospective cohort study

Authors: Samir Barghout, Luna Jia Zhan, Starvroula Raptis, Faisal Al-Agha, Niki Esfahanian, Aimee Popovacki, Goulnar Kasymjanova, Francis Proulx-Rocray, Sze Wah Samuel Chan, Matthew Richardson, Catherine Brown, Devalben Patel, Michelle Liane Dean, Vishal Navani, Erica Moore, Lane Carvery, Elizabeth Yan, Daniel Goldshtein, Jasmine Cleary-Gosine, Amanda JW Gibson, Lynn Hubley, Karmugi Balaratnam, Tran Ngo, Azee Gill, Morgan Black, Adrian Sacher, Penelope A. Bradbury, Frances A. Shepherd, Natasha Leighl, Parneet Cheema, Sara Kuruvilla, Jason Agulnik, Shantanu Banerji, Rosalyn Juergens, Normand Blais, Winson Cheung, Paul Wheatley-Price, Geoffrey Liu, Stephanie Snow

Stephen Liu

4. Atezolizumab Before and After Chemoradiation for Unresectable Stage III Non–Small Cell Lung Cancer

Authors: Helen Ross, David Kozono, Xiaofei Wang, James John Urbanic, Terence Williams, Garth Nelson, David Carbone, Dongjun Chung, Ryan Robb, Woo Yul Byun, Tiffany Talabere, Carter DuFrane, Ilze Bara, Katja Schulze, Michelle Brockman, Junheng Gao, Everett Vokes, Thomas Stinchcombe

Stephen Liu

5. RBM10 mutation as a potential negative prognostic/predictive biomarker to therapy in non-small-cell lung cancer

Authors: Amanda Reyes, Michelle Afkhami, Erminia Massarelli, Jeremy Fricke, Isa Mambetsariev, Xiaochen Li, Giovanny Velasquez, Ravi Salgia

Stephen Liu

Follow Stephen Liu on X for more such content.

Stephen Liu is an Associate Professor of Medicine at Georgetown University, where he holds the positions of Director of Thoracic Oncology and Head of Developmental Therapeutics at the Georgetown Lombardi Comprehensive Cancer Center.

As a board-certified medical oncologist specializing in lung cancer and drug development, Dr. Liu is known for his expertise in advanced thoracic malignancies. His research focuses on novel therapeutic agents and innovative combinations to improve treatment outcomes for patients with lung cancer.

Dr. Liu has received multiple teaching awards and actively engages in post-graduate education initiatives. Furthermore, he co-hosts the official podcast of the International Association for the Study of Lung Cancer (IASLC), “Lung Cancer Considered”.